here is higher than that in the right (Rohrer et al., 2012). However, FTD patients carrying MAPT mutations normally don't show asymmetric atrophy (Rohrer & Warren, 2011). These studies suggest an association of specific FTD gene mutations with asymmetric atrophy during dis- ease progression. Intriguing quest